Expression of functional NK 1 receptors in human alveolar macrophages: Superoxide anion production, cytokine release and involvement of NF-κβ pathway

British Journal of Pharmacology

Volumn 145, Issue 3, 2005, Pages 385-396

  Bardelli, Claudio ^a   Gunella, Gabriele ^a   Varsaldi, Federica ^a   Balbo, Pietro ^b   Del Boca, Elisa ^a   Bernardone, Ilaria Seren ^a   Amoruso, Angela ^a   Brunelleschi, Sandra ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

Cytokine release; Human alveolar macrophages; IL 1 ; IL 10; NF B activation; NK 1 receptor; Respiratory burst; Substance P; TNF

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P; SUBSTANCE P [9 PROLINE]; SUBSTANCE P [9 SARCOSINE 11 METHIONINE]; SUBSTANCE P DERIVATIVE; SUPEROXIDE; TOBACCO SMOKE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; FEMALE; GUINEA PIG; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; INFLAMMATION; INTRACELLULAR TRANSPORT; LUNG ALVEOLUS MACROPHAGE; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; RESPIRATORY BURST; SIGNAL TRANSDUCTION; SMOKING; WESTERN BLOTTING; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SECRETION;

ADULT; AGED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; NF-KAPPA B; RECEPTORS, NEUROKININ-1; SIGNAL TRANSDUCTION; SMOKING; SUBSTANCE P; SUPEROXIDES;

EID: 21244502600     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706198     Document Type: Article

References (45)

1. ANDREAKOS, E., SACRE, S.M., SMITH, C., LUNDBERG, A., KIRIAKIDIS, S., STONEHAUSE, T., MONACO, C., FELDMANN, M. & FOXWELL, B.M. (2004). Distinct pathways of LPS-induced NF-κb activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood. 103, 2229-2237.
2. BAI, T.R., ZHOU, D., WEIR, T., WALKER, B., HEGELE, R., HAYASHI, S., MCKAY, K., BONDY, G.P. & FONG, T. (1995). Substance P (NK-1)- and neurokinin A (NK-2)-receptor gene expression in inflammatory airway disease. Am. J. Physiol., 269, L309-L317.
3. BALDWIN, A.S. (1996). The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol., 14, 649-681.
4. BONDESON, J., BROWNE, K.A., BRENNAN, P.M., FOXWELL, B.M. & FELDMANN, M. (1999). Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent. J. Immunol., 162, 2939-2945.
5. BROWN, O.P., IWAMOTO, G.K., MONICK, M.M. & HUNNINGHAKE, G.W. (1989). Cigarette smoking decreases interleukin 1 release by human alveolar macrophages. Am. J. Physiol., 256, C260-C264.
6. BRUNELLESCHI, S., BORDIN, G., COLANGELO, D. & VIANO, I. (1998). Tachykinin receptors on human monocytes: their involvement in rheumatoid arthritis. Neuropeptides, 32, 215-223.
7. BRUNELLESCHI, S., GUIDOTTO, S., VIANO, I., FANTOZZI, R., POZZI, E., OHIO, P. & ALBERA, C. (1996). Tachykinin activation of human alveolar macrophages in tobacco smoke and sarcoidosis: a phenotypical and functional study. Neuropeptides, 30, 456-464.
8. BRUNELLESCHI, S., PARENTI, A., CENI, E., GIOTTI, A. & FANTOZZI, R. (1992). Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins. Br. J. Pharmacol., 107, 964-969.
9. BRUNELLESCHI, S., PENENGO, L., LAVAGNO, L., SANTORO, C., COLANGELO, D., VIANO, I. & GAUDINO, G. (2001). Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin. Br. J. Pharmacol., 134, 1285-1295.
10. BRUNELLESCHI, S., TARLI, S., GIOTTI, A. & FANTOZZI, R. (1991). Priming effects of mammalian tachykinins on human neutrophils. Life Sci., 48, PL1-PL5.
11. 2 receptors. Br. J. Pharmacol., 100, 417-420.
12. CABERLOTTO, L., HURD, Y.L., MURDOCK, P., WAHLIN, J.P., MELOTTO, S., CORSI, M. & CARLETTI, R. (2003). Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain. Eur. J. Neurosci., 17, 1736-1746.
13. CARTER, A.B., MONICK, M.M. & HUNNINGHAKE, G.W. (1998). Lipopolysaccharide-induced NF-κB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am. J. Respir. Cell. Mol. Biol., 18, 384-391.
14. DUSSER, D.J., DJOKIC, T.D., BORSON, D.B. & NADEL, J.A. (1989). Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea pig. Possible role of free radicals. J. Clin. Invest., 84, 900-906.
15. FARVER, C.F., RAYCHAUDHURI, B., BUHROW, L.T., CONNORS, M.J. & THOMASSEN, M.J. (1998). Constitutive NF-κB levels in human alveolar macrophages from normal volunteers. Cytokine, 10, 868-871.
16. FONG, T.M., ANDERSON, S.A., YU, H., HUANG, R.R. & STRADER, C.D. (1992). Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol. Pharmacol., 41, 24-30.
17. GERMONPRE, P.R., BULLOCK, G.R., LAMBRECHT, B.N., VAN DE VELDE, V., LUYTEN, W.H., JOOS, G. & PAUWELS, R.A. (1999). Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells. Eur. Respir. J., 14, 776-782.
18. 1 receptor antagonist, in the isolated spinal cord of the neonatal rat. Eur. J. Pharmacol., 281, 49-54.
19. HAGAN, R.M., IRELAND, S.J., JORDAN, C.C., BERESFORD, I.J.M., STEPHENS-SMITH, M.L., EWAN, G. & WARD, P. (1990). GR71251, a novel, potent and highly selective antagonist at neurokinin-1 receptors. Br. J. Pharmacol., 99, 62P.
20. HO, W.Z., LAI, J.P., ZHU, X.H., UVAYDOVA, M. & DOUGLAS, S.D. (1997). Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol., 159, 5654-5660.
21. IWAMOTO, I., NAKAGAWA, N., YAMAZAKI, H., KIMURA, A., TOMIOKA, H. & YOSHIDA, S. (1993). Mechanism for substance P-induced activation of human neutrophils and eosinophils. Regul. Pept., 46, 228-230.
22. KIM, K.H., PARK, K.C., CHUNG, J.H. & CHOI, H.R. (2003). The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis. J. Dermat. Sci., 32, 115-124.
23. LAI, J.P., DOUGLAS, S.D., SHAHEEN, F., PLEASURE, D.E. & HO, W.Z. (2002b). Quantification of Substance P mRNA in human immune cells by real-time reverse transcriptase PCR assay. Clin. Diagn. Lab. Immunol., 9, 138-143.
24. LAI, J.P., HO, W.Z., YANG, J.H.. WANG, X., SONG, L. & DOUGLAS, S.D. (2002a). A non-peptide substance P antagonist down-regulates SP mRNA expression in human mononuclear phagocytes. J. Neuroimmunol., 128, 101-108.
25. LAVAGNO, L., BORDIN, G., COLANGELO, D., VIANO, I. & BRUNELLESCHI, S. (2001). Tachykinin activation of human monocytes from patients with rheumatoid arthritis: in vitro and ex-vivo effects of cyclosporin A. Neuropeptides, 35, 92-99.
26. LAVAGNO, L., GUNELLA, G., BARDELLI, C, SPINA, S., FRESU, L.G., VIANO, I. & BRUNELLESCHI, S. (2004). Anti-inflammatory drugs and tumor necrosis factor-α production in monocytes: role of transcription factor NF-κB and implication in rheumatoid arthritis therapy. Eur. J. Pharmacol., 501, 199-208.
27. LI, H., LEEMAN, S.E., SLACK, B.E., HAUSER, G., SALTSMAN, W.S., KRAUSE, J.E., BLUSZTAJN, J.K. & BOYD, N.D. (1997). A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization, Proc. Natl. Acad. Sci. U.S.A., 94, 9475-9480.
28. LIEB, K., FIEBICH, B.L., BERGER, M., BAUER, J. & SCHULZE-OSTHOFF, K. (1997). The neuropeptide substance P activates transcription factor NF-κB and κB-dependent gene expression in human astrocytoma cells. J. Immunol., 159, 4952-4958.
29. LOTZ, M., VAUGHAN, J.H. & CARSON, D.A. (1988). Effects of neuropeptides on production of inflammatory cytokines by human monocytes. Science, 241, 1218-1221.
30. MANTYH, P.W., ROGERS, S.D., GHILARDI, J.R., MAGGIO, J.E., MANTYH, C.R. & VIGNA, S.R. (1996). Differential expression of two isoforms of the neurokinin-1 (substance P) receptor in vivo. Brain Res., 719, 8-13.
31. MARRIOTT, I. & BOST, K.L. (2000). IL-4 and IFN-γ up-regulate substance P receptor expression in murine peritoneal macrophages. J. Immunol., 165, 182-191.
32. MARRIOTT, I., MASON, M.J., ELHOFY, A. & BOST, K.L. (2000). Substance P activates NF-κB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J. Neuroimmunol., 102, 163-171.
33. MOUSLI, M., BRONNER, C., BUEB, J.L., TSCHIHART, E., GIES, J.P. & LANDRY, Y. (1989). Activation of rat peritoneal mast cells by substance P and mastoparan. J. Pharmac. Exp. Ther., 250, 329-335.
34. 4 receptor; a reappraisal. Eur. J. Pharmacol., 437, 27-30.
35. PASCUAL, D.W., XU-AMANO, J.C., KIYONO, H., MCGHEE, J.R. & BOST, K.L. (1991). Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production. J. Immunol., 146, 2130-2136.
36. PAYAN, D.G., BREWSTER, J.D. & GOETZL, E.J. (1983). Specific Stimulation of human T lymphocytes by substance P. J. Immunol., 131, 1613-1615.
37. PENNEFATHER, J.N., LECCI, A., CANDENAS, M.L., PATAK, E., PINTO, F.M. & MAGGI, C.A. (2004). Tachykinins and tachykinin receptors: a growing family. Life Sci., 74, 1445-1463.
38. RASLEY, A., BOST, K.L., OLSON, J.K., MILLER, S.D. & MARRIOTT, I. (2002). Expression of functional NK-1 receptors in murine microglia. Glia, 37, 258-267.
39. RAYCHAUDHURI, B., FISHER, C.J., FARVER, C.F., MALUR, A., DRAZBA, J., KAVURU, M.S. & THOMASSEN, M.J. (2000). Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine, 12, 1348-1355.
40. SEVERINI, C., IMPROTA, G., FALCONIERI-ERSPAMER, G., SALVADORI, S. & ERSPAMER, V. (2002). The tachykinin peptide family. Pharmacol. Rev., 54, 285-322.
41. SIMEONIDIS, S., CASTAGLIUOLO, I., PAN, A., LIU, J.L., WANG, C.C., MYKONIATIS, A., PASHA, A., VALENICK, L., SOUGIOULTZIS, S., ZHAO, D. & POTHOULAKIS, C. (2003). Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-κB site on its promoter. Proc. Natn. Acad. Sci. U.S.A., 100, 2957-2962.
42. SMITH, V.C., SAGOT, M.A., WONG, H. & BUCHAN, A.M.J. (2000). Cellular expression of the neurokinin 1 receptor in the human antrum. J. Autonom. Nerv. Syst., 79, 165-172.
43. TOMAKI, M., ICHINOSE, M., MIURA, M., HIRAYAMA, Y., YAMAUCHI, H., NAKAJIMA, N. & SHIRATO, K. (1995). Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am. J. Respir. Crit. Care Med., 151, 613-617.
44. WU, Z.X. & LEE, L.Y. (1999). Airway hyperresponsiveness induced by chronic exposure to cigarette smoke in guinea-pigs: role of tachykinins. J. Appl. Physiol, 87, 1621-1628.
45. YAMAGUCHI, E., OKAZAKI, N., ITOH, A., ABE, S., KAWAKAMI, Y. & OKUYAMA, H. (1989). Interleukin 1 production by alveolar macrophages is decreased in smokers. Am. Rev. Respir. Dis., 140, 397-402.